Halozyme Therapeutics, Inc.

Biotechnology company · San Diego, California, United States · Nasdaq: HALO

Halozyme Therapeutics, Inc. is a biotechnology company headquartered in San Diego, California, United States. Its shares trade on Nasdaq under the ticker HALO.

Profile compiled from public records. Is this your company? Request a correction or update

Halozyme Therapeutics at a glance

Typebiotechnology company

HeadquartersSan Diego, California, United States

Stock listingNasdaq: HALO

SEC industryBiological Products, (No Diagnostic Substances)

SEC CIK1159036

Frequently asked questions about Halozyme Therapeutics

Where is Halozyme Therapeutics headquartered?

Halozyme Therapeutics, Inc. is headquartered in San Diego, California, United States.

What does Halozyme Therapeutics do?

Halozyme Therapeutics, Inc. is a biotechnology company. Its SEC industry classification is Biological Products, (No Diagnostic Substances).

Is Halozyme Therapeutics a public company?

Yes. Halozyme Therapeutics, Inc. trades on Nasdaq under the ticker HALO.

Similar companies

BioAtla, Inc.San Diego, California, United States
Neurocrine Biosciences IncSan Diego, California, United States
ImmunityBio, Inc.San Diego, California, United States
Sorrento Therapeutics, Inc.San Diego, California, United States
Protego Biopharma, Inc.San Diego, California, United States
Tempo Therapeutics, Inc.San Diego, California, United States
Fate Therapeutics IncSan Diego, California, United States
ImageneBio, Inc.San Diego, California, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-25. Data licences